Week 9 quiz

Question 1 A nurse educator who coordinates the staff education on an oncology unit is conducting an inservice on targeted therapies. What potential benefit of targeted therapies should the nurse highlight in this education session?

Question 2 An oncology nurse is aware of the risks for injury that exist around the preparation, transportation, and administration of chemotherapeutic agents. In order to reduce these risks of injury, the nurse should take which of the following actions?

Question 3 A patient has just received her first dose of imatinib and the nurse on the oncology unit is amending the patient’s care plan accordingly. What nursing diagnosis is most appropriate in light of this addition to the patient’s drug regimen?

Question 4 A nurse has administered filgrastim to a diverse group of patients in recent months. Which of the following patients should the nurse observe for extremely elevated white blood cell counts following administration of the drug?

Question 5 A patient with chronic lymphocytic leukemia (CLL) will imminently begin a course of treatment with rituximab. In order to minimize the risk of adverse effects, what strategy for administration will be adopted?

Question 6 A 45-year-old woman with acute leukemia is going to begin chemotherapy with vincristine. The nurse is aware that vincristine must always be administered

Question 7 Mr. Singh is a 66-year-old man who is receiving chemotherapy for the treatment of lung cancer that has metastasized to his liver. In an effort to prevent infection, Mr. Singh has been prescribed filgrastim (Neupogen). Which of the nurse’s following assessment questions most directly addresses a common adverse effect of filgrastim?

Question 8 A 67-year-old man who is being treated for prostate cancer is taking epoetin alfa. The nurse will instruct the patient to

Question 9 A male patient is receiving heparin by continuous intravenous infusion. The nurse will instruct the patient and family members to report which of the following should it occur?

Question 10 A nurse is caring for a 64-year-old female patient who is receiving IV heparin and reports bleeding from her gums. The nurse checks the patient’s laboratory test results and finds that she has a very high aPTT. The nurse anticipates that which of the following drugs may be ordered?

Question 11 A nurse has been assigned to a 55-year-old woman who has a malignant brain tumor. The patient is receiving her first dose of carmustine. It will be critical for the nurse to observe for which of the following?

Question 12 A nurse is assessing a patient who has chronic lymphoblastic myelogenous leukemia. The treatment plan includes hydroxyurea (Hydrea). The nurse will assess the patient for which of the following? NURS 6521 Week 9 Quiz Paper

Question 13 A patient’s current course of cancer treatment involves the administration of a conjugated monoclonal antibody. What characteristic of the drug is specified by the fact that it is classified as a conjugated drug?

Question 14 An oncology nurse is reviewing the pathophysiology of cancer and is discussing with a colleague the factors that contribute to the success or failure of a patient’s chemotherapy. Which of the following cancerous cells is most susceptible to the effects of chemotherapeutic drugs?

Question 15 A patient receiving high-dose cisplatin therapy exhibits symptoms of hypomagnesemia. Which of the following should the nurse suggest to help offset the magnesium losses from the cisplatin therapy?

Question 16 An older adult woman has been diagnosed with acute lymphoblastic leukemia (ALL) and her care team has identified potential benefits of imatinib. Which of the following characteristics of this patient’s current health status may preclude the use of imatinib?

Question 17 A female patient is prescribed oprelvekin therapy to treat thrombocytopenia. Which of the following should the nurse continuously monitor to determine the efficacy and duration of the oprelvekin therapy?

Question 18 During ongoing assessment of a patient receiving 5-FU therapy, the nurse finds the patient’s platelet count to be 92,000 cells/mm3. The nurse should do which of the following?

Question 19 A nurse has been assigned to a female patient who is to begin chemotherapy. The nurse will initiate the prescribed oprelvekin therapy

Question 20 A patient with a recent diagnosis of chronic myelogenous leukemia (CML) is discussing treatment options with his care team. What aspect of the patient’s condition would contraindicate the use of cyclophosphamide for the treatment of leukemia?

Question 21 A female patient has follicular non-Hodgkin’s lymphoma and is receiving thalidomide (Thalomid). It will be most important for the nurse to monitor this patient for which of the following?

Question 22 When planning care for a patient who is receiving filgrastim (Neupogen) for a nonmyeloid malignancy, the nurse should formulate which of the following patient outcomes? (Select all that apply.)

Question 23 A nurse is to use a single-dose 1 mL vial to administer 0.5 mL of epoetin alfa to a 39-year-old woman who is being treated for chemotherapy-induced anemia. Which of the following will the nurse do with the unused portion of the drug?

Question 24 nurse is discussing oprelvekin therapy with a male patient. Which of the following will the nurse tell the patient is the most common adverse effect of the drug?

Question 25 A patient with chronic heart failure has begun treatment with epoetin alfa, which she will receive in her own home from a home health nurse. The nurse should teach the patient to supplement this treatment with a diet that is high in … NURS 6521 Week 9 Quiz Paper

Question 26 A nurse is administering rituximab to a patient via the IV route. The nurse will set the IV pump at 50 mg/hour for the first half hour of the initial infusion. If there are not apparent reactions after 30 minutes of the infusion, the nurse will increase the dosage every 30 minutes by 50 mg/hour until the maximum infusion rate reaches which of the following?

Question 27 A 62-year-old patient taking tamoxifen exhibits increased bone and tumor pain along with a local disease flare. The nurse interprets this as an indication of which of the following?

Question 28 A male patient is receiving rituximab therapy for non-Hodgkin’s lymphoma. Which of the following would be a priority nursing intervention to reduce the risk for cytotoxicity and tumor lysis syndrome?

Question 29 A patient with a diagnosis of chronic myeloid leukemia has met with her oncologist, who has recommended treatment with the kinase inhibitor imatinib. What route of administration should the nurse explain to the patient?

Question 30 A 60-year-old patient experienced a sudden onset of chest pain and shortness of breath and was subsequently diagnosed with a pulmonary embolism in the emergency department. The patient has been started on an intravenous heparin infusion. How does this drug achieve therapeutic effect?

Question 31 A male patient has been on long-term bicalutamide (Casodex) therapy. In order to assess adverse effects of the drug therapy, the nurse will closely monitor which of the following?

Question 32 Intravenous carmustine has been prescribed for a patient with cancer. The nurse should help relieve the discomfort of pain and burning during the infusion by … NURS 6521 Week 9 Quiz Paper

Question 33 A middle-aged patient has received a diagnosis of GI stromal tumor following an extensive diagnostic workup. Imatinib has been recommended as a component of the patient’s drug regimen. What patient education should the nurse provide to this patient?

Question 34 A nurse has completed a medication reconciliation of a patient who has been admitted following a motor vehicle accident. Among the many drugs that the patient has received in the previous year is rituximab. The nurse would be justified in suspecting the patient may have received treatment for which of the following diseases?

Question 35 Mr. Lepp is a 63-year-old man who was diagnosed with colon cancer several weeks ago and who is scheduled to begin chemotherapy. He reports to the nurse that he read about the need for erythropoietin in an online forum for cancer patients and wants to explore the use of epoetin alfa with his oncologist. Which of the following facts should underlie the nurse’s response to Mr. Lepp? NURS 6521 Week 9 Quiz Paper

MORE INFO 

Benefits of targeted therapies

Introduction

Cancer is a disease that affects millions of people around the world. It’s not just a physical illness, it also has an emotional impact on those who suffer from it and their loved ones. Many people feel helpless when they hear about cancer diagnosis or are told that they have a terminal illness. However, there are new therapies being developed by scientists that may help patients fight back against this devastating disease by targeting specific genes, proteins or tissue environments that contribute to cancer growth.

No impact on your stomach and bowels

Targeted therapies do not affect your stomach and bowels. They are designed to target cancer cells, but they do not affect healthy cells or the normal function of your digestive system. This means that you will not get any side effects from targeted therapy because it does not enter the bloodstream and therefore does not cause harm to other organs in your body.

If you have had radiation therapy for a head or neck cancer, there is a chance that some of the drugs used during radiation can be absorbed into your bloodstream via urine or stool (stool). If this happens, then doctors may recommend another drug called 5-flurouracil (5FU) which acts as an antibiotic but also helps kill off any remaining traces of cancerous cells left over after surgery or radiation treatment.

No hair loss

• No hair loss. While your hair may be the first thing you notice about yourself, it’s not the only one. You’ll also notice that you have less of an appetite and are less likely to vomit or experience nausea after treatment.

• Less side effects and fewer hospitalizations during cancer treatments. If a person experiences side effects from their cancer treatment—which can include nausea, vomiting, diarrhea and constipation as well as fatigue—it can be difficult for them to continue with the treatment plan due to discomfort or pain related to these symptoms being experienced too often throughout the day (or night). However, if targeted therapies are administered regularly instead of being given sporadically when needed by patients struggling with these issues at home then there won’t be any need for emergency medical care which means less stress on those going through this difficult time in their lives while still getting all their prescribed medications in order before starting chemotherapy again later down line!

Can delay or avoid bone marrow transplantation

Bone marrow transplantation is a last resort for people with leukaemia, lymphoma or myeloma. It can be an effective treatment for some people and is more effective if it is given early on in the disease. However, it has side effects that make it difficult to use as a first line of treatment.

Bone marrow transplantation involves removing stem cells from one part of your body (for example, bone marrow) and then injecting them into another part of your body (for example, blood).

Potential to cure chronic leukaemias and lymphomas

Targeted therapies are targeted at specific genes or proteins. They can be used to treat a number of different cancers, including some rare forms of leukaemia.

Targeted therapies are less toxic than chemotherapy and have fewer side effects, making them a good choice for patients who don’t want to experience lots of side effects while they’re undergoing treatment.

Side effects are often manageable

Side effects are often manageable.

In general, the side effects of targeted therapies are mild and short-lived. The frequency of side effects depends on the type of targeted therapy you take and your overall health. Some people may experience mild nausea or diarrhea; others may have an upset stomach or constipation; some people may be more sensitive to certain medications than others (for example, some people with arthritis might experience joint pain at higher doses). If these symptoms do occur during treatment, it’s important to talk with your healthcare provider about managing them with medication or making lifestyle changes as needed.

Some targeted therapies can treat cancer without the need for chemotherapy by targeting the specific genes, proteins or the tissue environment that contributes to cancer growth.

Targeted therapies are often used in combination with other treatments. In some cases they can be used to treat cancer without the need for chemotherapy by targeting the specific genes, proteins or the tissue environment that contributes to cancer growth.

Targeted therapies have been found to be effective against many types of tumors such as breast cancer and colorectal cancer. In addition, targeted therapies have been shown to improve outcomes when used along with other types of treatments like radiation therapy or surgery.

Conclusion

Based on our findings, it seems that targeted therapies offer an excellent way to treat certain types of cancer without the need for conventional chemotherapy. We hope these potential benefits will encourage people with cancer to seek out this type of treatment as soon as possible!